Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Blood tests for players at FIFA Confederations Cup
2009-03-21

Football stars coming to South Africa to play in the FIFA Confederations Cup tournament in June will not only have their urine tested for illegal substances but their blood as well.

This will be the first time that blood samples from sportsmen or women will be tested in South Africa.

“Blood testing is a new regulation from the World Anti-Doping Agency (WADA) and will be implemented in our laboratory for the FIFA Confederations Cup in June,” according to Dr Pieter van der Merwe, Head of the SA Doping Control Laboratory at the University of the Free State (UFS), the only testing facility of its kind in Southern Africa.

Although urine will still be tested, blood tests have become compulsory, because the substances used by sports men and women are becoming more sophisticated.

“Some substances, such as the growth hormone, can more easily be detected in blood. It is more difficult to determine these kinds of substances in urine,” explained Dr Van der Merwe.

“We were contracted by the International Rugby Board (IRB) to conduct the testing for the 7’s World Cup Rugby Tournament that was recently held in Dubai and by FIFA to do the testing for the Confederations Cup this year as well as the 2010 World Cup. This demonstrates the confidence of International Sport Federations in the quality and standard of work produced by this facility at the UFS,” he said.

The results of all tests done for the national programme in South Africa are sent to the Institute for Drug Free Sport based in Cape Town from where it is reported to the various sports federations. However, the rugby and soccer results are reported directly to the IRB and FIFA respectively.

The move to incorporate blood tests in the testing process has resulted in the expansion of the facility’s infrastructure.

“A new extension will be built for us in the near future in order for us to accommodate the conducting of urine and blood testing,” says Dr van der Merwe.

Media Release
Issued by: Anton Fisher
Director: Strategic Communication
Tel: 051 401 2749
Cell: 072 207 8334
E-mail: fishera.stg@ufs.ac.za  
20 March 2009

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept